pheS * , an effective host-genotype-independent counter-selectable marker for marker-free chromosome deletion in Bacillus amyloliquefaciens

Appl Microbiol Biotechnol. 2017 Jan;101(1):217-227. doi: 10.1007/s00253-016-7906-9. Epub 2016 Oct 11.

Abstract

Aside from applications in the production of commercial enzymes and metabolites, Bacillus amyloliquefaciens is also an important group of plant growth-promoting rhizobacteria that supports plant growth and suppresses phytopathogens. A host-genotype-independent counter-selectable marker would enable rapid genetic manipulation and metabolic engineering, accelerating the study of B. amyloliquefaciens and its development as both a microbial cell factory and plant growth-promoting rhizobacteria. Here, a host-genotype-independent counter-selectable marker pheS * was constructed through a point mutation of the gene pheS, which encodes the α-subunit of phenylalanyl-tRNA synthetase in Bacillus subtilis strain 168. In the presence of 5 mM p-chloro-phenylalanine, 100 % of B. amyloliquefaciens strain SQR9 cells carrying pheS * were killed, whereas the wild-type strain SQR9 showed resistance to p-chloro-phenylalanine. A simple pheS * and overlap-PCR-based strategy was developed to create the marker-free deletion of the amyE gene as well as a 37-kb bmy cluster in B. amyloliquefaciens SQR9. The effectiveness of pheS * as a counter-selectable marker in B. amyloliquefaciens was further confirmed through the deletion of amyE genes in strains B. amyloliquefaciens FZB42 and NJN-6. In addition, the potential use of pheS * in other Bacillus species was preliminarily assessed. The expression of PheS* in B. subtilis strain 168 and B. cereus strain ATCC 14579 caused pronounced sensitivity of both hosts to p-chloro-phenylalanine, indicating that pheS * could be used as a counter-selectable marker (CSM) in these strains.

Keywords: B. amyloliquefaciens; Counter-selectable marker; Unmarked genetic manipulation; pheS *.

MeSH terms

  • Anti-Bacterial Agents / toxicity
  • Bacillus amyloliquefaciens / genetics*
  • Bacillus amyloliquefaciens / physiology
  • Bacillus subtilis / genetics
  • Bacillus subtilis / physiology
  • Fenclonine / toxicity
  • Gene Knockout Techniques / methods*
  • Genetics, Microbial / methods*
  • Genotype
  • Microbial Viability / drug effects
  • Mutant Proteins / genetics
  • Mutant Proteins / metabolism
  • Phenylalanine-tRNA Ligase / genetics*
  • Phenylalanine-tRNA Ligase / metabolism
  • Point Mutation
  • Selection, Genetic*

Substances

  • Anti-Bacterial Agents
  • Mutant Proteins
  • Phenylalanine-tRNA Ligase
  • Fenclonine